Sharon Shechter

Sharon Shechter is a seasoned professional in the field of biochemistry and bioinformatics, currently serving as Principal Scientific Product Owner at Novo Nordisk. Previous roles include Director of Computational Chemistry at Psivant Therapeutics, Director of Platform Integration at Roivant Sciences, and Project Manager and Principal Investigator at Silicon Therapeutics. Sharon Shechter holds a Doctor of Philosophy in Biochemistry from the University of Massachusetts Lowell, expected to be completed in October 2024, and a Master of Arts in Bioinformatics from Northeastern University, earned in 2007.